Clinical trials are increasingly using liquid biopsy samples to complement or as an alternative to invasive tissue sample collections. With the increasing complexity and diversity of biomarkers to include for clinical trials stratification, liquid biopsy panels that enable Comprehensive Genomic Profiling (CGP) allows consolidation of individual biomarkers into a single NGS assay. In addition, sophisticated bioinformatics solutions allow for the detection of variants at low allelic frequencies, making the assay suitable for biomarker development programs and clinical trial use. In this webinar, we will discuss critical workflow and bioinformatics considerations when consolidating biomarkers testing into a panel that enables CGP from liquid biopsy samples in clinical trials.
Stephanie Hastings, Ph.D
Staff Scientist II, Assay Development,
Translational Genomics
Q² Solutions
Details
Fill Out Form to Access Webinar
Your email address is never shared with third parties.
- Date & Time
- 20 Aug 2020
- 9:00 AM PDT
- Location
- North America
- Affiliation
- Stephanie Hasting, Ph.D Staff Scientist II, Assay Development, Translational Genomics Q² Solutions
- Presenter
- Stephanie Hasting, Ph.D
- Topic
- Oncology